These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 305443)

  • 1. Molecular basis of B cell activation: mitogenicity of native and modified digitalis glycosides.
    Hammarström LL; Smith CI
    J Immunol; 1978 Mar; 120(3):694-9. PubMed ID: 305443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Species restriction of the mitogenicity induced by lanatoside C. Lymphocyte activation by digitalis glycosides is confined to cells from digitalis resistant species.
    Hammarström L; Smith CI
    Immunology; 1979 Jun; 37(2):389-96. PubMed ID: 157324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum-mediated suppression of nonspecific B cell activation. I. Description of an inhibitory capacity in normal mouse serum and characterization of the inhibitory component.
    Walker SM; Sturtevant JE; Weigle WO
    J Immunol; 1981 May; 126(5):1852-56. PubMed ID: 6163819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte activation. VI. A re-evaluation of factors affecting the selectivity of polyclonal mitogens for mouse T and B cells.
    Doenhoff MJ; Janossy G; Greaves MF; Gomer KJ; Snajdr J
    Clin Exp Immunol; 1974 Jul; 17(3):475-90. PubMed ID: 4549690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein I and protein II from the outer membrane of Escherichia coli are mouse B-lymphocyte mitogens.
    Bessler WG; Henning U
    Z Immunitatsforsch Immunobiol; 1979 Jun; 155(5):387-98. PubMed ID: 382663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lanatoside C, a new polyclonal B-cell activator.
    Hammarström L; Smith CI
    Cell Immunol; 1978 Mar; 36(2):377-82. PubMed ID: 305296
    [No Abstract]   [Full Text] [Related]  

  • 7. Influenza viruses as lymphocyte mitogens. I. B cell mitogenesis by influenza A viruses of the H2 and H6 subtypes is controlled by the I-E/C subregion of the major histocompatibility complex.
    Scalzo AA; Anders EM
    J Immunol; 1985 Feb; 134(2):757-60. PubMed ID: 3155540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LPS regulation of the immune response: separate mechanisms for murine B cell activation by lipid A (direct) and polysaccharide (macrophage-dependent) derived from Bacteroides LPS.
    Williamson SI; Wannemuehler MJ; Jirillo E; Pritchard DG; Michalek SM; McGhee JR
    J Immunol; 1984 Nov; 133(5):2294-300. PubMed ID: 6332842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of B lymphocytes by mycoplasma mitogen(s).
    Naot Y; Ginsburg H
    Immunology; 1978 Apr; 34(4):715-20. PubMed ID: 309850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of acyl residues in polyclonal murine B cell activation by acylpoly(1,3)galactosides from Klebsiella pneumoniae.
    Hmama Z; Lina G; Normier G; Binz H; Revillard JP
    J Immunol; 1993 Nov; 151(10):5440-9. PubMed ID: 8228237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of B cell activation by prostaglandins: cell cycle-specific effects on activation by anti-immunoglobulin and 8-mercaptoguanosine.
    Goodman MG
    J Immunol; 1986 Dec; 137(12):3753-7. PubMed ID: 3491148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary in vitro antibody responses by purified murine B lymphocytes in serum-free defined medium.
    Mosier DE
    J Immunol; 1981 Oct; 127(4):1490-3. PubMed ID: 6792277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody (AE3.d3) with mitogenic properties for murine B cells.
    Allouche M; Basch RS; Berman JW
    J Immunol; 1984 Nov; 133(5):2301-7. PubMed ID: 6384364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of mouse B-cell activation by beta-adrenoceptor stimulation depending on type of mitogens.
    Li YS; Kouassi E; Revillard JP
    Immunology; 1990 Mar; 69(3):367-72. PubMed ID: 2155873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of serum inhibitor on the antigenic and mitogenic responses to E. coli bacteria.
    Poe WJ; Michael JG
    J Immunol; 1976 Apr; 116(4):1129-33. PubMed ID: 768380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the calcium requirement for the induction and maintenance of B cell class II molecule expression and for B cell proliferation stimulated by mitogens and purified growth factors.
    Dennis GJ; Mizuguchi J; McMillan V; Finkelman FD; Ohara J; Mond JJ
    J Immunol; 1987 Jun; 138(12):4307-12. PubMed ID: 2438339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The type-specific capsular carbohydrate of Hemophilus influenzae B is a potent mitogen for murine B lymphocytes.
    Lucas AH; Asser SM
    J Immunol; 1986 Nov; 137(10):3130-4. PubMed ID: 3490510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-mediated suppression of nonspecific B cell activation. II. Relative resistance of B cells from the NZB mouse strain to regulation by a natural inhibitor in normal mouse serum.
    Walker SM; Sturtevant JE; Weigle WO
    J Immunol; 1981 Sep; 127(3):1204-7. PubMed ID: 6973581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B-lymphocyte mitogenicity in vitro of a synthetic lipopeptide fragment derived from bacterial lipoprotein.
    Bessler WG; Johnson RB; Wiesmüller K; Jung G
    Hoppe Seylers Z Physiol Chem; 1982 Jul; 363(7):767-70. PubMed ID: 6751983
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoregulation of B cell growth by an immunoglobulin M autoantibody.
    Kiely JM; Braun J; Unanue ER
    J Immunol; 1985 Aug; 135(2):1040-5. PubMed ID: 3874225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.